About LabInCube
LabInCube is a company based in Cheongju-si (South Korea) founded in 2021.. LabInCube has raised $3.78 million across 1 funding round from investors including KIPVC, Union Investment Partners and BNH INVESTMENT. LabInCube offers products and services including PlLacube Pink Ball and Industrial Filters. LabInCube operates in a competitive market with competitors including PanTher Therapeutics, PolyPid, Zyl Therapeutics, Santen Pharmaceuticals and Lexaria Bioscience, among others.
- Headquarter Cheongju-si, South Korea
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$3.78 M (USD)
in 1 rounds
-
Latest Funding Round
$3.78 M (USD), Series A
Apr 04, 2024
-
Investors
KIPVC
& 2 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of LabInCube
LabInCube offers a comprehensive portfolio of products and services, including PlLacube Pink Ball and Industrial Filters. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Enhances skin anti-aging with combined PLLA and PN components.
Captures specific gases for industrial and air purification uses.
Funding Insights of LabInCube
LabInCube has successfully raised a total of $3.78M through 1 strategic funding round. The most recent funding activity was a Series A round of $3.78 million completed in April 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Series A — $3.8M
-
First Round
First Round
(04 Apr 2024)
- Investors Count 3
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr, 2024 | Amount | Series A - LabInCube | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in LabInCube
LabInCube has secured backing from 3 investors, including institutional and venture fund investors. Prominent investors backing the company include KIPVC, Union Investment Partners and BNH INVESTMENT. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Growth stage tech and offline focused venture capital firm investing primarily in South Korea
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location | |
|
Early to growth stage PE and VC investments are conducted.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by LabInCube
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - LabInCube
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Labincube Comparisons
Competitors of LabInCube
LabInCube operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as PanTher Therapeutics, PolyPid, Zyl Therapeutics, Santen Pharmaceuticals and Lexaria Bioscience, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Drug delivery systems for inoperable solid tumors are developed.
|
|
| domain | founded_year | HQ Location |
Technology platform enabling controlled and prolonged release of any Active Pharmaceutical Ingredient (API)
|
|
| domain | founded_year | HQ Location |
Hydrogel-derived nanoparticles for topical drug delivery are developed.
|
|
| domain | founded_year | HQ Location |
Pharmaceutical products for ophthalmology and rheumatology diseases are manufactured.
|
|
| domain | founded_year | HQ Location |
Patented drug delivery technology is developed for bioactive molecules.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about LabInCube
When was LabInCube founded?
LabInCube was founded in 2021 and raised its 1st funding round 3 years after it was founded.
Where is LabInCube located?
LabInCube is headquartered in Cheongju-si, South Korea. It is registered at Cheongju-si, North Chungcheong, South Korea.
Who is the current CEO of LabInCube?
Kyeongmin Choi is the current CEO of LabInCube.
Is LabInCube a funded company?
LabInCube is a funded company, having raised a total of $3.78M across 1 funding round to date. The company's 1st funding round was a Series A of $3.78M, raised on Apr 04, 2024.
What does LabInCube do?
LabInCube was founded in 2021 in Cheongju-si, South Korea, focusing on the medical devices and pharmaceuticals sector. InCube technology is utilized to integrate molecular spacing and sustained release methods, reducing substance degradation while enabling controlled drug delivery over extended periods. Medical devices are created for selective drug release, supporting ongoing health management. Operations center on innovation in drug delivery systems.
Who are the top competitors of LabInCube?
LabInCube's top competitors include PanTher Therapeutics, PolyPid and Lexaria Bioscience.
What products or services does LabInCube offer?
LabInCube offers PlLacube Pink Ball and Industrial Filters.
Who are LabInCube's investors?
LabInCube has 3 investors. Key investors include KIPVC, Union Investment Partners, and BNH INVESTMENT.